Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease
NCT01948518
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Parenchymal Lung Disease
Pulmonary Hypertension
Interventions
DRUG:
Oral sildenafil 20 mg
Sponsor
The Cleveland Clinic